Product Images Trivora

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Trivora NDC 51862-510 by Mayne Pharma Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

trivora 01

trivora 01

trivora 02

trivora 02

trivora 03

trivora 03

trivora 04

trivora 04

This appears to be a table with the names of different studies and their corresponding effect estimates. The studies are related to women's contraceptive use and include the NICHD Women's Contraceptive Study, French E3N cohort Study, Shangsi Womens Health Study, Nurses' Health Study I, and the Oxford Family Planning Association Study. The table also includes information on current use and the Danish Sex Hormone Register Study. The format and information suggest that this is a statistical analysis report.*

trivora 05

trivora 05

trivora 06

trivora 06

NDC 51862-510-06 is a 28-day regimen of Trivora, which is a combination of levonorgestrel and ethinyl estradiol tablets USP in a triphasic regimen. The pack contains 6 blue tablets, each with levonorgestrel 0.05 mg and ethinyl estradiol 0.03 mg; 5 white tablets, each with levonorgestrel 0.075 mg and ethinyl estradiol 0.04 mg; 10 pink tablets, each with levonorgestrel 0.125 mg and ethinyl estradiol 0.03 mg; and 7 peach tablets with inert ingredients. The tablets should be taken as directed, and the full prescribing information should be consulted. The medication is distributed by Mayne Pharma and manufactured by Patheon, Inc. Rx Only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.